Association of Ex Vivo Drug Response ( EVDR) and Clinical Outcome in Acute Myeloid Leukaemia (EXCYTE-2)

Clinical trial NCT06648512 · COMPLETED

Trial details

NCT number: NCT06648512
Sponsor: Exscientia AI Limited
Status: COMPLETED
Study type: OBSERVATIONAL

Acute Myeloid Leukemia (AML)Acute Myeloid Leukemia (AML) Relapse

Start date: 2024-05-13
Primary completion: 2025-03-07
Enrollment: 91

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.